GeekWire
Menu
  • Home
  • News
    • Amazon
    • Civic presented by Microsoft
    • Geek Life presented by Network of Giving
    • Health/Life Sciences
    • Microsoft
    • Podcasts
    • Space
    • Startups
    • Sustainability
    • Tech Moves
    • Bot or Not
    • GeekWire on the Road: Spokane
    • Microsoft at 50 presented by Accenture
    • Tech Vets presented by Northern Trust
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • Amazon Office Buildings
    • GeekWire 200 presented by JPMorganChase
    • GeekWire Startup List
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nebius at NVIDIA GTC 2025 sponsored by Nebius
    • AWS Marketplace Seller Conference 2024 sponsored by AWS
    • AWS Summit: New York Partner Spotlights sponsored by AWS
    • Does Compute presented by Carnegie Mellon University
    • Guide to re:Invent sponsored by AWS
    • Money Hacks presented by BECU
    • Tech Connect at Dreamforce 2024 sponsored by RSM US LLP
    • Uncommon Thinkers Welcome sponsored by Greater Seattle Partners
    • Zuper at Inbound sponsored by Zuper
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
    • Sponsors
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What happens here matters everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Health/Life Sciences

Seattle-area health officials to require vaccination proof for bars, restaurants, and other public venues

Faced with filling hospitals, serious infection rates and aggressive new COVID-19 variants, King County’s Department of Health will require proof… Read More

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

Alpine Immune Sciences will move a potential treatment for immune conditions into human testing and support its ongoing trials for… Read More

Predicting weight loss: Study suggests gut bacteria may influence ability to shed pounds

A study led by Seattle’s Institute for Systems Biology suggests that the composition of the bacteria in the gut may… Read More

Health software company Edifecs acquires Talix in deal to boost value-based care

Bellevue, Wash.-based health software company Edifecs has acquired Talix, a San-Francisco based startup that mines language in health data to… Read More

Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing

CaaMTech, a Seattle-area startup developing new psychedelic agents, has raised $22 million in funding, the company announced this week. The… Read More

Seattle startup RareCyte raises $24M to advance new high-speed cell imaging platform

Seattle-based startup RareCyte announced $24 million in new funding on Thursday to advance its applications for the analysis of cells.… Read More

University of Washington awarded $16M for ‘third phase’ of human genome research

University of Washington scientists will help decode how variations in DNA influence health and disease with $16 million in new… Read More

Cyrus Bench on laptop

Seattle startup Cyrus inks protein-design deal with immune biotech Selecta worth up to $1.5 billion

Seattle-based Cyrus Biotechnology is entering a protein engineering collaboration with Boston-based Selecta Biosciences that could pull in up to $1.5… Read More

Gut check at Nordstrom: Retail giant to sell microbiome test from Seattle-area startup Viome

Nordstrom has paired up with Seattle-area startup Viome Life Sciences to sell kits that analyze the microbiome, the collection of… Read More

A-Alpha Bio founders

University of Washington spinout A-Alpha Bio snags $20M for protein-discovery platform

A-Alpha Bio will build lab space in downtown Seattle and beef up its machine learning team with $20 million in… Read More

Study: Blood self-collection device from a Seattle startup accurate for COVID-19 antibody samples

A self-administered device to collect blood yields high-quality antibody samples and works successfully in a high proportion of users, according… Read More

Impel NeuroPharma, fresh off IPO, gets FDA approval for nasal spray that treats migraines

The U.S. Food and Drug Administration has approved Impel NeuroPharma’s Trudhesa to treat migraine headaches, the Seattle company announced Friday.… Read More

These biotech and life sciences CEOs made the leap from software startups — here’s how they did it

In the past several years the barriers between tech and the life sciences have begun to dissolve. AI and machine… Read More

98point6 CEO Robbie Cape is no longer with the company in abrupt shakeup at telemedicine startup

98point6 CEO Robbie Cape is no longer working at the heavily-funded virtual healthcare company he helped start in 2015, GeekWire… Read More

Edmond Fischer, 1920-2021: Univ. of Washington biochemist won Nobel Prize for protein research

Edmond Fischer, Nobel Laureate and emeritus professor at the University of Washington biochemistry department, died peacefully in Seattle on Aug.… Read More

Diagnostics startup ID Genomics snags NIH grant to develop rapid test for COVID-19 variants

Diagnostics startup ID Genomics will accelerate its development of a quick test for variants of the COVID-19 virus with a… Read More

Seattle biotech firm Shape Therapeutics inks gene therapy deal with Roche worth up to $3B

Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene… Read More

Biotech companies fuel IPO boom in Washington state over the past year

In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped… Read More

Busy pandemic season helps medical supply e-commerce platform Bttn raise $5M

A Seattle-based e-commerce platform that aims to reduce costs and eliminate the middleman in the procurement of medical supplies has… Read More

New 130K square-foot drug manufacturing plant in Seattle area will develop COVID-19 therapeutics

The Seattle area is home to a new nimble drug manufacturing facility built by Just – Evotec Biologics that was… Read More

Athira Pharma extends Alzheimer’s clinical trial, adds new execs after CEO placed on leave

Athira Pharma is advancing its clinical trials in the wake of allegations of image manipulation in papers authored by its… Read More

Visus Therapeutics lands $20M to develop eye drop that corrects vision loss

Visus Therapeutics, a Seattle-based startup developing a presbyopia-correcting eye drop, raised $20 million. The fresh cash comes just six months… Read More

Seattle startup Lumen Bioscience is working with Google to make drugs using algae

Can machine learning help spur the production of algae-based biologics? That’s the question new research from Seattle biotech startup Lumen… Read More

Eliem is latest Seattle-area biotech to go public, raises $80M to help fuel treatments for nervous system disorders

Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares at $12.50 and raising… Read More

After ‘punch in mouth,’ Hillrom will proceed with $367M deal to acquire Seattle’s Bardy Diagnostics

Update: Hillroom’s acquisition of Bardy was completed late in the day on Friday, according to an SEC filing. Original story:… Read More

Vera Whole Health reels in $50M from healthcare arm of JP Morgan Chase

Seattle-based Vera Whole Health has raised $50 million from Morgan Health, the healthcare arm of JP Morgan Chase. The announcement Thursday… Read More

Tadataka Yamada, 1945-2021: Pioneer in drug development led global health at Gates Foundation

Tadataka Yamada, a pioneer in drug and vaccine development who helped forge numerous biotech companies and spent five years at… Read More

Sonoma Biotherapeutics raises $265M to advance therapies for autoimmune, inflammatory diseases

Seattle and South San-Francisco based preclinical biotech company Sonoma Biotherapeutics has raised $265 million in new funding, the company announced… Read More

Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company

Icosavax is having quite the debut as Washington state’s newest public company. Shares of the Seattle-based biotech firm surged more… Read More

‘We’ve been instrumental’: How Seattle became a hub for COVID-19 vaccine research

When the COVID-19 pandemic hit, University of Washington scientist Deborah Fuller did a quick pivot to the new virus. Her… Read More

  • Older
  • Newer

Latest Stories

    Read All Stories

    GeekWire Newsletters

    Subscribe to GeekWire's free newsletters to catch every headline

    Send Us a Tip

    Have a scoop that you'd like GeekWire to cover? Let us know.

    Send Us a Tip

    A Word From Our Sponsors

    About

    • About GeekWire
    • Contact Us
    • Partner With Us
    • Become a GeekWire Member
    • Send Us a Tip
    • Join Our Startup List
    • Reprints and Permissions

    Follow

    • Facebook
    • X
    • LinkedIn
    • Instagram
    • RSS Feed
    • Podcast
    • YouTube
    • Bluesky

    GeekWire Newsletters

    Catch every headline in your inbox

    Read GeekWire

    • Apple News
    • Google News

    Legal

    • Privacy Policy
    • Terms of Use
    • Sponsored Content Policy
    Return to Top of Page
    © 2011-2025 GeekWire, LLC
    Do Not Sell or Share My Personal information
    Limit the Use Of My Sensitive Personal Information
    Consent Preferences